Skip to main content
Log in

Histopathological diagnosis of appendiceal neuroendocrine neoplasms: when to perform a right hemicolectomy? A systematic review and meta-analysis

  • Meta-Analysis
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Purpose

The European Neuroendocrine Tumor Society (ENETS) guidelines advocate a right hemicolectomy (RHC) only in patients with appendiceal neuroendocrine neoplasms (aNENs) at risk for N+(node positive). The risk is defined using site, size, and grading of tumor as well as mesoappendiceal or lymphovascular invasion.

Methods

A systematic review and meta-analysis was carried out. The data were reported using risk difference (RD) to define the risk of N+. The number needed to treat/harm (NNT/NNH) and the likelihood of being helped or harmed (LHH) were calculated using RD. Two strategies were considered: “to treat all” versus “to treat only patients having aNENs with risk stigmata”. The aim was to evaluate the harm/benefit ratio related to the use of the ENETS lymph-nodal metastases (N+) risk factors.

Results

Six studies were included involving a total of 261 patients. The RD (−0.30; P < 0.001) of N+ was significantly lower in aNENs ≤ 20 mm as compared to those >20 mm. One unnecessary RHC every five patients (NNT = 5) could be avoided while 1 patient with N+ every six patients (NNH = 6) remained untreated. The risk was lower than the benefits (LHH = 1.2). The RD NNT, NNH, and LHH values suggested that only a 15 mm cutoff and the presence of lymphovascular invasion could be considered useful.

Conclusions

An RHC should be performed in patients with aNENs >20 mm. The use of a 15 mm cutoff criterion had a similar outcome to that of a 20 mm cutoff. Lymphovascular invasion should only be considered a minor criterion. Selection based on other parameters should be avoided

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Abbreviations

ENETS:

European Neuroendocrine Tumor Society

NANETS:

North American Neuroendocrine Tumor Society

aNEN:

Appendiceal neuroendocrine neoplasm

RHC:

Right hemicolectomy

RD:

Risk difference

N+:

Node positive

NNT:

Number needed to treat

NNH:

Number needed to harm

LHH:

Likelihood of being helped or harmed

WHO:

World Health Organization

95% CI:

95% Confidence interval

PRISMA:

Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement.

References

  1. I.M. Modlin, K.D. Lye, M. Kidd, A 5-decade analysis of 13,715 carcinoid tumors. Cancer 97, 934–959 (2003)

    Article  Google Scholar 

  2. K. Hemminki, X. Li, Incidence trends and risk factors of carcinoid tumors: a nationwide epidemiologic study from Sweden. Cancer 92, 2204–2210 (2001)

    Article  CAS  Google Scholar 

  3. M.H. Kulke, R.J. Mayer, Carcinoid tumors. N. Engl. J. Med 340, 858–868 (1999)

    Article  CAS  Google Scholar 

  4. U.F. Pape, B. Niederle, F. Costa et al. ENETS consensus guidelines for neuroendocrine neoplasms of the appendix (excluding goblet cell carcinomas. Neuroendocrinology 103(2), 144–152 (2016)

    Article  CAS  Google Scholar 

  5. J.P. Boudreaux, D.S. Klimstra, M.M. Hassan et al. The NANETS consensus guidelines for the diagnosis and management of neuroendocrine tumors: well differentiated neuroendocrine tumors of the jejunum, ileum, appendix, and cecum. Pancreas 39, 753–766 (2010)

    Article  Google Scholar 

  6. D.R. Heller, R.A. Jean, J. Luo et al. Practice patterns and guideline non-adherence in surgical management of appendiceal carcinoid tumors. J. Am. Coll. Surg. 228, 839–851 (2019) [Epub ahead of print]

    Article  Google Scholar 

  7. A. Liberati, D.G. Altman, J. Tetzlaff et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339, b2700 (2009)

    Article  Google Scholar 

  8. C. Ricci, R. Casadei, G. Taffurelli et al. Sporadic small (≤20 mm) nonfunctioning pancreatic neuroendocrine neoplasm: is the risk of malignancy negligible when adopting a more conservative strategy? a systematic review and meta-analysis. Ann. Surg. Oncol. 24, 2603–2610 (2017)

    Article  Google Scholar 

  9. K.I. Alexandraki, J. Griniatsos, K.I. Bramis et al. Clinical value of right hemicolectomy for appendiceal carcinoids using pathologic criteria. J. Endocrinol. Invest. 34, 255–259 (2011)

    Article  CAS  Google Scholar 

  10. N. Boxberger, A. Redlich, C. Böger et al. Neuroendocrine tumors of the appendix in children and adolescents. Pedia. Blood Cancer 60, 65–70 (2013)

    Article  Google Scholar 

  11. S. Grozinsky-Glasberg, K.I. Alexandraki, D. Barak et al. Current size criteria for the management of neuroendocrine tumors of the appendix: are they valid? Clinical experience and review of the literature. Neuroendocrinology 98, 31–37 (2013)

    Article  CAS  Google Scholar 

  12. G. de Lambert, H. Lardy, H. Martelli et al. Surgical management of neuroendocrine tumors of the appendix in children and adolescents: a retrospective French multicenter study of 114 cases. Pedia. Blood Cancer 63, 598–603 (2016)

    Article  Google Scholar 

  13. B. Rault-Petit, C. Do Cao, S. Guye´tant, et al. Current management and predictive factors of lymph node metastasis of appendix neuroendocrine tumors. Ann. Surg. (2018) [Epub ahead of print]

  14. N. Brighi, S. La Rosa, G. Rossi, et al. Morphological factors related to nodal metastases in neuroendocrine tumors of the appendix: a multicentric retrospective study. Ann. Surg. (2018) [Epub ahead of print]

  15. C. Ricci, R. Casadei, V. Alagna et al. A critical and comprehensive systematic review and meta-analysis of studies comparing intracorporeal and extracorporeal anastomosis in laparoscopic right hemicolectomy. Lange. Arch. Surg. 402, 417–427 (2017)

    Article  Google Scholar 

  16. S. Partelli, M. Mazza, V. Andreasi, F. Muffatti, S. Crippa, D. Tamburrino, M. Falconi. Management of small asymptomatic nonfunctioning pancreatic neuroendocrine tumors: limitations to apply guidelines into real life. Surgery (2019)

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Claudio Ricci.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Presented as poster at the 16th Annual Meeting of the European Neuroendocrine Tumor Society 6–8 March 2019.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ricci, C., Ingaldi, C., Alberici, L. et al. Histopathological diagnosis of appendiceal neuroendocrine neoplasms: when to perform a right hemicolectomy? A systematic review and meta-analysis. Endocrine 66, 460–466 (2019). https://doi.org/10.1007/s12020-019-01984-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-019-01984-z

Keywords

Navigation